Thus, BCL2 translocations were more frequently found in GCB-DLBCL (70% in GCB-DLBCL vs. 9% in non-GCB, p = 0.007), while BCL2 gains were only found in non-GCB-DLBCL (54% vs. 0%, p < 0.001), independently of the type of BM infiltration. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.